We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




First Clinical-Grade Diagnostic Wrist-Worn Device Designed for Long Term Monitoring of Atrial Fibrillation

By HospiMedica International staff writers
Posted on 04 Dec 2023

Wearable technology has the potential to significantly aid in the detection and management of atrial fibrillation (AF), a common heart rhythm disorder. More...

However, current consumer wrist-worn devices using photoplethysmography-based algorithms are limited to intermittent checks and are not designed for clinical decision-making. Recognizing this gap, researchers have developed a wearable wristwatch that offers continuous monitoring of heart rhythm and employs an innovative algorithm for AF detection.

Developed by a team at the University of Michigan, the Verily Study Watch stands out as a clinical-grade device. It operates on a principle similar to other wearables, using photoplethysmography to monitor heart rhythm changes. Unique to this device, if AF is detected, it prompts the wearer to take a single-lead ECG for confirmation. This result is then verified by a cardiographic technician before being communicated to the patient's doctor. This device constantly analyzes data, checking every 15 minutes. Over a period from September 2020 to May 2021, it was tested on over 100 participants, proving its effectiveness in identifying AF with an accuracy rate comparable to other photoplethysmography-based devices. While there was a noted dip in performance for detecting AF in participants with darker skin, it nonetheless was successful in identifying AF cases in these patients.

This research is the first to evaluate the performance of a photoplethysmography-based algorithm in detecting AF across all physical activity levels. The Verily Study Watch maintained its accuracy in detecting AF during both low and moderate physical activities. Unlike consumer-oriented devices like the Apple Watch and Fitbit, which are FDA-approved only for pre-diagnostic use, the Verily Study Watch bridges the gap, potentially enabling healthcare providers to leverage wearable data for patient management. The FDA has granted 510(k) clearance to Verily, acknowledging the device's efficacy and its comparability to other legally marketed medical devices.

“Right now, we typically manage patients with atrial fibrillation using electrocardiogram, or ECG, patches that we put on the chest, but the future of Afib management will be on the wrist,” said Hamid Ghanbari, M.D., M.P.H., a cardiac electrophysiologist the University of Michigan Health Frankel Cardiovascular Center. “It is not intended to replace interval ECG monitoring for patients who need it. However, the multistage system may also limit the burden on clinicians and avoid the deluge of notifications generated by other wrist-worn devices that rarely result in clinically actionable findings.”

Related Links:
University of Michigan 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mattress System
Apollo Infant Dynamic
New
Pediatric Cast Saw
CSP-201 Quietcast
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.